Literature DB >> 1093892

Macrophage-lymphocyte interaction and antigen recognition.

A S Rosenthal, P E Lipsky, E M Shevach.   

Abstract

The functional and morphologic aspects of immunologically relevant macrophage-lymphocyte interaction have been characterized in inbred guinea pigs. Antigen-dependent initiation of in vitro DNA synthesis in lymphocytes taken from animals previously immunized with that antigen has been shown to be macrophage dependent. Expression of this in vitro correlate of in vivo established cellular immunity requires that antigen is initially bound to macrophages antecedent to any interaction with the specific lymphocyte. In view of the failure of supernatants from macrophages briefly exposed to antigen to initiate DNA synthesis in immune lymphocytes and the critical density requirements for lymphocyte proliferation, it is reasonable to assume that a direct physical interaction occurs between the antigen-bearing macrophage and lymphocyte. Using an in vitro assay of lymphocyte binding to macrophage monolayers, we have characterized what appear to be sequential events in macrophage-lymphocyte interaction. The initial event is an antigen-independent interaction between macrophage and lymphocyte whose characteristics are rapid reversibility, species but not strain specificity, and dependence on macrophage metabolism. If macrophages bear antigen for which a given lymphocyte possesses a specific receptor, then a second nonreversible antigen-dependent stabilization of binding occurs. This latter step requires tht macrophage and lymphocyte be histocompatible. These observations parallel functional studies of the histocompatibility dependence of macrophage-associated antigen initiation of lymphocyte DNA synthesis in guinea pigs. A model sequence of the physical events correlating with functional macrophage-lymphocyte interaction is proposed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093892

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  17 in total

1.  Role of major histocompatibility complex gene products in delayed-type hypersensitivity.

Authors:  J F Miller; M A Vadas; A Whitelaw; J Gamble
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

2.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

Review 3.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

4.  Complement bridges between cells analysis of a possible cell-cell interaction mechanism.

Authors:  M P Dierich; B Landen
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

Review 5.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

6.  Murine macrophage-lymphocyte interactions: scanning electron microscopic study.

Authors:  R M Albrecht; R D Hinsdill; P L Sandok; S D Horowitz
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Macrophage-T cell interaction mediated by immunogenic and non-immunogenic forms of a monofunctional antigen.

Authors:  S Fong; P Chen; D E Nitecki; J W Goodman
Journal:  Mol Cell Biochem       Date:  1979-06-15       Impact factor: 3.396

8.  Biological and clinical relevance of human macrophage migration inhibitory factor (MIF).

Authors:  L H Block; G Ruhenstroth-Bauer
Journal:  Blut       Date:  1979-02-19

9.  The expression of Fc and complement receptors in young, adult and aged mice.

Authors:  V Vĕtvicka; L Fornůsek; J Zídková
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

10.  Human monocyte killing of Staphylococcus aureus: modulation by agonists of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate.

Authors:  M S O'Dorisio; G R Vandenbark; A F LoBuglio
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.